Channel Sponsor - Valuation

Sponsored by VMG Health | gregk@vmghealth.com | (214) 369-4888

AmSurg Shares Rise in Value After $2.35B Sheridan Deal Announcement

Share on Facebook
Raymond James analyst John Ransom set AmSurg’s price target at $60 and upgraded his recommendation to “buy,” according to a Value Walk report.

The upgrade was made closely following AmSurg’s announcement of intention to acquire Sheridan Healthcare for $2.35 billion.

More Articles on Transactions and Valuation Issues:
4 Recent ASC Industry Acquisitions
Beloit Health System ASC Project Remains in Limbo
3 Recently Opened & Expanded Ambulatory Surgery Centers

© Copyright ASC COMMUNICATIONS 2014. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

 

New From Becker's ASC Review

St. Vincent Anderson Regional to open $26M surgical pavilion

Read Now